123 related articles for article (PubMed ID: 16154045)
1. Can flowcytometric DNA studies forecast the prognosis of endometrial hyperplasia?
Sherif LS; Totongy M; Tawfeek M; Abdel-Ghafar H; Badawy AM
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):104-6. PubMed ID: 16154045
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy, cell cycle kinetics, and low versus high grade atypia in endometrial hyperplasia.
Michael H; Kotylo PK; Mohr M; Roth LM
Am J Clin Pathol; 1996 Jul; 106(1):22-8. PubMed ID: 8701927
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric DNA analysis of abnormal endometrium.
Sato S; Tanoguchi K; Tase T; Yajima A
Tohoku J Exp Med; 1996 Feb; 178(2):199-202. PubMed ID: 8727701
[TBL] [Abstract][Full Text] [Related]
4. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data.
Agorastos T; Bontis J; Vakiani A; Vavilis D; Constantinidis T
Gynecol Oncol; 1997 Apr; 65(1):102-14. PubMed ID: 9103399
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry (FCM) analysis of endometrial hyperplasia and carcinoma.
Kysela B; Siracký J; Redecha M; Bárdos A
Neoplasma; 1990; 37(5):489-95. PubMed ID: 2234210
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry as a prognostic method for the identification of adenomatous hyperplasia at risk of developing endometrial carcinoma.
Lindahl B; Willén R
Anticancer Res; 1998; 18(6B):4611-2. PubMed ID: 9891527
[TBL] [Abstract][Full Text] [Related]
7. DNA image cytometry in the differential diagnosis of endometrial hyperplasia and adenocarcinoma.
Biesterfeld S; Leitloff M; Rath W; Schröder W
Anal Quant Cytol Histol; 2001 Apr; 23(2):123-8. PubMed ID: 11332078
[TBL] [Abstract][Full Text] [Related]
8. [Nuclear DNA content of parathyroid tumor with hyperparathyroidism].
Suzuki S; Ando Y; Ami H; Furukawa H; Tsuchiya A; Abe R
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():486-91. PubMed ID: 9589058
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis of stromal hyperplasia of the endometrium (author's transl)].
Zippel HH; Citoler P
Pathol Res Pract; 1980 Oct; 169(2):192-9. PubMed ID: 6160566
[TBL] [Abstract][Full Text] [Related]
10. [Expression of epidermal growth factor receptor and plasmatic level of melatonin in simple and complex endometrial hyperplasia].
Dznelashvili NO; Kasradze DG; Tavartkiladze AG; Mariamidze AG; Dzhinchveladze DN
Georgian Med News; 2013 Oct; (223):91-5. PubMed ID: 24214601
[TBL] [Abstract][Full Text] [Related]
11. The value of MRI in management of endometrial hyperplasia with atypia.
Natarajan P; Vinturache A; Hutson R; Nugent D; Broadhead T
World J Surg Oncol; 2020 Feb; 18(1):34. PubMed ID: 32041614
[TBL] [Abstract][Full Text] [Related]
12. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
13. Detection of chromosomal anomalies in endometrial atypical hyperplasia and carcinoma by using fluorescence in situ hybridization.
Qian J; Weber D; Cochran R; Hossain D; Bostwick DG
Cancer Cytopathol; 2010 Apr; 118(2):97-104. PubMed ID: 20225199
[TBL] [Abstract][Full Text] [Related]
14. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
[TBL] [Abstract][Full Text] [Related]
15. [Characteristic of cystic glandular hyperplasia as a precursor of endometrial carcinoma].
Yokosuka K; Teshima H; Yamakawa Y; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1241-6. PubMed ID: 7844442
[TBL] [Abstract][Full Text] [Related]
16. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.
Kurman RJ; Kaminski PF; Norris HJ
Cancer; 1985 Jul; 56(2):403-12. PubMed ID: 4005805
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric cell cycle kinetics and quantitative measurement of c-erbB-2 and mutant p53 proteins in normal, hyperplastic, and malignant endometrial biopsies.
Eissa S; Abu Saada M; el-Sharkawy T
Clin Biochem; 1997 Apr; 30(3):209-14. PubMed ID: 9167896
[TBL] [Abstract][Full Text] [Related]
19. Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women.
Tabatabaie A; Karimi Zarchi M; Dehghani-Tafti M; Miratashi-Yazdi A; Teimoori S; Dehghani A
Eur J Gynaecol Oncol; 2013; 34(6):552-5. PubMed ID: 24601050
[TBL] [Abstract][Full Text] [Related]
20. Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing".
D'Angelo E; Espinosa I; Cipriani V; Szafranska J; Barbareschi M; Prat J
Am J Surg Pathol; 2021 Jul; 45(7):988-996. PubMed ID: 34105519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
